6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Can-Fite BioPharma Ltd.
Filed: January 16, 2026
Period of Report: January 16, 2026
Accession Number: 0001213900-26-005150

View Document ↗ View on SEC.gov ↗